This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...
HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...
The Brighterside of News on MSN
Tiny human heart organoids open the door to safer, faster drug discovery
Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...
This content is sponsored by MedStar Washington Hospital Center. Atrial fibrillation, or AFib, is the most common type of arrhythmia (an abnormal or irregular heartbeat caused by a disturbance in the ...
Key takeawaysAn international panel of more than 80 experts has issued updated guidance to improve care for atrial fibrillation (AF) patients ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and treating atrial fibrillation, a condition that significantly raises the risks ...
LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The ...
Multifocal atrial arrhythmia is an uncommon type of tachycardia that usually develops in people with certain illnesses. Those with the condition have a heart rate of over 100 beats per minute.
If you have a racing or irregular heartbeat, also known as an arrhythmia, one likely suspect is atrial fibrillation (AFib). “Of all the possible heart rhythm disorders, atrial fibrillation is by far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results